CMV Action is partnering with Swansea and Cardiff Universities, University College London and Imperial College London under the NIHR London In Vitro Diagnostics Co-operative in a project to develop a rapid, low cost, human CMV diagnostic biosensor device which can rapidly detect CMV in saliva or urine with no sample processing. 

CMV Action will be part of the steering group, providing patient and public involvement advice (PPI) and helping to ensure that the voice parents and patients affected by congenital CMV is heard. 

Calls will shortly be made for volunteers to take part in the project and we will carry details on our website and in social media when the recruitment process opens.